A-shares closed · 港股休市 Quotes 行情 · 28 Sep 12:48 CST
28 Sep 2026 · 12:48 CST Terminal Access 终端入口 →
920344.BJ北京证券交易所 · 北交所 BSE

Tri-Prime Gene 三元基因

Biologics 生物制品
¥22.64+¥0.79 · +3.62%Delayed 行情延迟 · 28 Sep 2026 · 12:05 CST · CNY
Open 开盘
¥22.42
High 最高
¥23.50
Low 最低
¥21.50
Prev Close 昨收
¥21.85
Volume 成交量
544.5万股
Turnover 成交额
¥1.23亿
Mkt Cap 总市值
¥28亿
P/E 市盈率
206.5×
Recent Activity 近期动态All Filings 全部公告 →

11 significant filings since 31 May 2026: 2 on regulatory inquiry, 8 on share issue and 1 on guarantee or financial assistance. The latest, on 30 Jun 2026: 关于对北京证券交易所2025年年报问询函回复的公告.
自 31 May 2026 起有 11 份重大公告:regulatory inquiry 2 份、share issue 8 份、guarantee or financial assistance 1 份。最新一份(30 Jun 2026):关于对北京证券交易所2025年年报问询函回复的公告。

Price History 价格走势

1,250 trading days 个交易日 · High 最高 ¥36.22 · Low 最低 ¥13.80
15.0020.0025.0030.00
Volume 成交量
1,438.7万
20212022202420252026

Against Its Own History 与自身历史比较

206.5×
Median 中值 113.7× · Range 区间 56.2× to 586.2× · 10 periods 期
4.40×
Median 中值 3.71× · Range 区间 2.90× to 5.37× · 14 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥18.96¥0.10189.6×¥5.153.68×
31 Mar 2026 一季报¥19.29¥0.15128.6×¥5.153.75×
31 Dec 2025 年报¥23.45¥0.04586.2×¥5.144.56×
30 Sep 2025 三季报¥26.74−¥0.04—¥4.985.37×
30 Jun 2025 中报¥24.66¥0.05493.2×¥5.044.89×
31 Mar 2025 一季报¥23.65¥0.06394.2×¥5.004.73×
31 Dec 2024 年报¥17.79¥0.1898.8×¥5.103.49×
30 Sep 2024 三季报¥18.01¥0.2766.7×¥5.013.59×
30 Jun 2024 中报¥14.60¥0.2656.2×¥5.032.90×
31 Mar 2024 一季报¥18.95¥0.2770.2×¥5.043.76×
31 Dec 2023 年报¥21.84¥0.2684.0×¥5.024.35×
30 Sep 2023 三季报¥15.44——¥4.843.19×
30 Jun 2023 中报¥16.16——¥4.813.36×
31 Mar 2023 一季报¥15.20——¥4.743.20×

Consensus Forward EPS 机构预测每股收益

Fiscal Year 年度EPS Median 中值Range 区间Brokers 机构数Forward P/E 预测市盈率
2026¥0.17¥0.17 to ¥0.171133.2×
2027¥0.30¥0.30 to ¥0.30175.5×
2028¥0.35¥0.35 to ¥0.35164.7×
Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA